Open AccessPrevalence of irritable bowel syndrome and metabolic syndrome among young adults in an annual health check‐up setting
Author(s) -
Javadekar Narendra S,
Oka Gauri A,
Joshi Ashwini S,
Vaste Parag,
Tamane Sandeep,
Lawate Parimal S
Publication year - 2021
Publication title -
jgh open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.546
H-Index - 8
ISSN - 2397-9070
DOI - 10.1002/jgh3.12639
Subject(s) - metabolic syndrome , medicine , irritable bowel syndrome , dyslipidemia , waist , anthropometry , body mass index , gastroenterology , diabetes mellitus , obesity , cross sectional study , endocrinology , pathology
Background and Aim Some studies have found a positive association between irritable bowel syndrome (IBS) and metabolic syndrome; however, none are from India. Methods We conducted a cross‐sectional study of 1040 adults aged between 18 and 50 years. Individuals from the annual health check‐up setting were screened using anthropometry and biochemistry. Based on the results, they were identified as with and without metabolic syndrome. We excluded individuals who were already diagnosed with metabolic syndrome or those who were already on medication for diabetes mellitus or hypertension or dyslipidemia. All the participants were administered the Rome III questionnaire for the diagnosis of IBS. Results Metabolic syndrome was found in 307 of 1040 (29.5%) while 33 of 1040 (3.2%) had IBS. The proportion of IBS was not significantly different between participants with and without metabolic syndrome (1.6% vs 3.8% respectively; P = 0.06). Those with IBS had significantly greater mean weight (72.4 vs 67.2 kg; P = 0.009), mean waist circumference (88.8 vs 85.2 cm; P = 0.011), mean body mass index (BMI) (26.2 vs 24.2 kg/m 2 ; P = 0.002), and higher mean fasting glucose (96 vs 89 mg/dL; P < 0.000) respectively. Conclusion The prevalence of metabolic syndrome and IBS are comparable to previous literature from India. There was no association between metabolic syndrome and IBS.